Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Dow
McKesson
Express Scripts
AstraZeneca

Last Updated: August 9, 2022

Litigation for SITAGLIPTIN PHOSPHATE


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


US Court Litigation for SITAGLIPTIN PHOSPHATE

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
7,326,708 Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. See Plans and Pricing 2019-05-02 2019-08-09 35:271 Patent Infringement District Court, N.D. West Virginia None See Plans and Pricing
7,326,708 See Plans and Pricing See Plans and Pricing 2019-05-02 2019-08-09 35:271 Patent Infringement District Court, N.D. West Virginia None See Plans and Pricing
7,326,708 Merck Sharp & Dohme Corp. v. Mylan Pharmaceuticals Inc. See Plans and Pricing 2019-05-02 2019-08-09 35:271 Patent Infringement District Court, N.D. West Virginia None See Plans and Pricing
7,326,708 Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc. See Plans and Pricing 2019-02-12 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
7,326,708 Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc. See Plans and Pricing 2019-02-12 2021-03-01 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
7,326,708 Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc. See Plans and Pricing 2019-02-12 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
7,326,708 Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc. See Plans and Pricing 2019-02-13 35:271 Patent Infringement District Court, D. Delaware None See Plans and Pricing
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for SITAGLIPTIN PHOSPHATE

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
7,326,708 Mylan Pharmaceuticals, Inc. See Plans and Pricing 2019-10-30 11-14-2019 Cypes et al Inter partes review See Plans and Pricing 05-12-2020 See Plans and Pricing
7,326,708 Teva Pharmaceuticals USA, Inc. See Plans and Pricing 2020-06-10 06-10-2020 Cypes et al Inter partes review See Plans and Pricing 09-01-2020 See Plans and Pricing
7,326,708 Dr. Reddy's Laboratories, Inc. See Plans and Pricing 2020-06-11 06-11-2020 Cypes et al Inter partes review See Plans and Pricing 09-01-2020 See Plans and Pricing
7,326,708 Sun Pharmaceutical Industries Ltd. See Plans and Pricing 2020-06-12 06-12-2020 Cypes et al Inter partes review See Plans and Pricing 09-01-2020 See Plans and Pricing
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Medtronic
Merck
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.